Bipolar disorder - Articles - Page 4

Bipolar Treatment Upgrade Part I

July 10, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates from the 2023 International Bipolar Conference, including new diagnostic tools for bipolar disorder. Stanford researchers propose a new subtype of depression.

Psychopharm Commandment #10: Don’t Fear these Meds

May 29, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

Research Update

Marginal Results for Levetiracetam in Mania

April 14, 2023

Kamron Fariba, MD

Kamron Fariba, DO. Dr. Fariba has no financial relationships with companies related to this material.

This anticonvulsant makes its randomized-controlled debut in bipolar mania.

Research Update

L-Methylfolate May Offer Modest Boost to Antidepressants

April 14, 2023

Glen Spielmans, PhD

Glen Spielmans, PhD. Dr. Spielmans has no financial relationships with companies related to this material.

A meta-analysis of this FDA-cleared supplement.

Research Update

Do Antidepressants Have Any Role in Acute Bipolar Depression?

April 14, 2023

Marilyn J. Vaché, MD. Dr. Vaché has no financial relationships with companies related to this material.

A meta-analysis finds little benefit, but it may depend on the type of bipolar.

Research Update

Adjuvant Clonidine for Mania

March 8, 2023

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.

Clonidine was a promising therapy for mania in the 1980s, but the ball got dropped. This study picks that up with a modern-day randomized-controlled design.

Pregnancy and Psychiatric Medications

December 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates on the management of psych meds during pregnancy and breastfeeding, with help from Anita Clayton, MD

EXPERT Q&A

Treatment-Resistant Depression

September 25, 2022

Charles DeBattista, MD

Charles DeBattista, MD

Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA.

Dr. DeBattista has reported receiving research funding from Relmada, Compass, Janssen, Biolite, Myriad, Neurocentia, Beckley, and Sage, and has served as a consultant for Abvie, Sage, and Corcept. This article was reviewed by Dr. Aiken, Editor-in-Chief, who has concluded that there is no evidence of commercial bias in this educational activity.

Charles DeBattista offers tips for working with patients with treatment-resistant depression.

Understanding the Varieties of Depression

September 25, 2022

Ronald Pies, M.D.

Ronald W. Pies, MD

Professor Emeritus of Psychiatry and Lecturer on Bioethics and Humanities, SUNY Upstate Medical University; Clinical Professor of Psychiatry, Tufts University School of Medicine; Editor-in-Chief Emeritus, Psychiatric Times.

Dr. Pies, expert for this educational activity, has disclosed no relevant financial relationship(s) with ineligible companies to disclose.

Depression is not one illness, but how divide it up? Ronald Pies highlights subtypes of
depression worth paying attention to in practice.